This message was sent to ##Email##
|
|
|
|
|
ASPET
 ASPET Awards recognize excellence in scientific research by individuals from all career stages in the field of pharmacology. Nominating a colleague or a mentor has never been easier with our new Awards Portal. Check it out and nominate someone before September 15, 2015!
LEARN MORE
ASPET
 Members are invited to participate in the second cycle of the ASPET BIG IDEAS Initiative. Take the lead in bringing forth your big idea to benefit the society and the discipline of pharmacology. Submit your initial proposal by September 28, 2015.
LEARN MORE
ASPET
 Members can now post open postdoctoral positions from their institutions to the ASPET Career Center for a discounted rate of only $100. The discounted rate includes all-inclusive promotion of the open position on ASPET's social media channels, jobs feed on the ASPET website, and our bi-monthly news brief.
POST JOB
ASPET
 Are you interested developing your science policy and advocacy skills? Want to visit Capitol Hill to meet with your congressional delegate to advocate for biomedical research? If you are a graduate student, postdoctoral trainee, or researcher no more than four years past the completion of his/her postdoctoral training, apply now for the ASPET Washington Fellows Program.
LEARN MORE
ASPET
 On July 8th, the full House Appropriations Committee approved the fiscal year (FY) 2016 Agriculture Appropriations Bill by a voice vote.
READ MORE
ASPET
The Bipartisan Policy Center has released a new report with recommendations designed to spur innovation by reforming FDA policies with several proposed reforms aligned closely with the 21st Century Cures legislation, Inside Health Policy reports.
LEARN MORE
ASPET
 On July 28th, the FDA released draft guidance detailing plans to use quality metrics data to further develop the FDA's risk-based inspection scheduling.
READ MORE
ASPET
PULSE is soliciting their first round of annual applications for New PULSE Fellows from life sciences faculty members. As a PULSE Fellow you will create programs to support departmental reform, propel organizational change, develop standards of excellence, build regional networks, and promote connections among national organizations with similar missions.
LEARN MORE
ASPET
This eight week course offered through Coursera will provide graduate students and post-doctoral fellows in the STEM disciplines who are planning college and university faculty careers effective teaching strategies for college or university STEM (science, technology, engineering, mathematics) classrooms.
LEARN MORE
ASPET
Effective July 20, 2015, figures in manuscripts considered for acceptance in ASPET's four wholly owned journals will be examined for evidence of manipulation. Inappropriate image manipulation will result in rejection of the manuscript.
LEARN MORE
ASPET
 Pharmacology Research and Perspectives (PR&P) is inviting submissions of several types of special articles, with particular interest in articles on target validation.
LEARN MORE
ASPET
 A special section on Pediatric Drug Disposition and Pharmacokinetics is being planned for publication in the April 2016 issue of Drug Metabolism and Disposition. Submit your paper by October 1, 2015.
LEARN MORE
| | ASPET ANNUAL MEETING NEWS |
ASPET
It's time to pick your abstract category and prepare your abstracts for submission to the 2016 Experimental Biology meeting. Abstract submissions to EB 2016 will open in September and are due by November 5, 2015.
LEARN MORE
ASPET
ASPET's Career Center resources help you look for jobs in your area of specialty and proactively manage your career goals. Don't forget to view our current job listings!
Pharmacology Faculty Position — West Virginia School of Osteopathic Medicine, Lewisburg, WV
Assistant Professor — Washington University School of Medicine, St. Louis, MO
Pharmacology — Xavier University of Louisiana, New Orleans, LA
Faculty Positions — Pharmaceutical Sciences — St. Jude Children's Research Hospital, Memphis, TN
Scientist, Preclinical and Translational Pharmacokinetics/Pharmacodynamics (PTPK) — Genentech, South San Francisco, CA
Scientist/Senior Scientist — Drug Metabolism and Pharmacokinetics (DMPK) — In Vitro — Genentech, South San Francisco, CA
Scientist, Preclinical and Translational Pharmacokinetics/Pharmacodynamics (PTPK) - Genentech, South San Francisco, CA
Assistant/Associate/Full Professor of Developmental Cancer Therapeutics - Univ of California, Davis, CA
CLICK HERE FOR MORE JOBS
ASPET
If your department has a job opening, consider posting your job on the ASPET Career Center. Not only will your job be seen by members visiting our website, but we also market our jobs to members through our bi-monthly Newsbrief and to our over 1,700 LinkedIn Group members.
LEARN MORE
The Medical News
Scientists believe that a treatment to prevent or delay the symptoms of Huntington's disease could now be much closer, following a major breakthrough. There is currently no cure for Huntington’s disease, but the findings, published in the journal Cell, suggest that it could be possible to delay its effects or even prevent it altogether, allowing people with the Huntington's gene to live healthy lives for longer.
READ MORE
Quartz
Your body is a reservoir for bacteria and viruses as much as it is a bag of your own cells. Some of these are disease-causing agents, lurking in waiting for an opportunity to attack. This is a huge problem for those with HIV, the virus that eventually leads to AIDS. Now, researchers have found a cancer drug that can attack dormant HIV reservoirs.
READ MORE
R&D Magazine
A vaccine containing virus-like nanoparticles, or microscopic, genetically engineered particles, is an effective treatment for respiratory syncytial virus, according to researchers. Their findings, published in the International Journal of Nanomedicine, suggest this vaccine induces long-term protection against RSV and could be a novel treatment option for this disease. There is no licensed RSV vaccine.
READ MORE
Neuroscience News
A targeted therapy already used to treat advanced skin cancer is also effective against the most common subtype of the brain tumor medulloblastoma in adults and should be considered for treatment of newly diagnosed patients, according to research led by St. Jude Children's Research Hospital. The drug, called vismodegib, is designed to block a key protein in the sonic hedgehog signaling pathway.
READ MORE
PBS NewsHour
Major pharmaceutical companies are reportedly recruiting thousands of recreational drug users to test a new generation of medicines that deter addiction, which could have a significant impact in the fight against prescription drug addiction. Financial Times reporter David Crow joins Hari Sreenivasan to explain the drug tests.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
